These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. In vitro susceptibility of Haemophilus influenzae to cefaclor, cefixime, cefetamet and loracarbef. Williams JD; Powell M; Fah YS; Seymour A; Yuan M Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):748-51. PubMed ID: 1425737 [TBL] [Abstract][Full Text] [Related]
5. Comparative susceptibilities of ampicillin and chloramphenicol resistant Haemophilus influenzae to fifteen antibiotics. Campos J; Garcia-Tornel S J Antimicrob Chemother; 1987 Mar; 19(3):297-301. PubMed ID: 3494722 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of new antibiotics against Haemophilus influenzae. Machka K; Balg H; Braveny I Eur J Clin Microbiol Infect Dis; 1988 Dec; 7(6):812-4. PubMed ID: 3145871 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity of cefixime (CL284635) and other antimicrobial agents against Haemophilus isolates from pediatric patients. Kumar A; Kelly KJ Chemotherapy; 1988; 34(1):30-5. PubMed ID: 3258232 [TBL] [Abstract][Full Text] [Related]
8. Activities of newer beta-lactam antibiotics against ampicillin, chloramphenicol, or multiply-resistant Haemophilus influenzae. Strandberg DA; Jorgensen JH; Drutz DJ Diagn Microbiol Infect Dis; 1984 Sep; 2(4):333-7. PubMed ID: 6333316 [TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activity of cefixime against Haemophilus influenzae isolates, including ampicillin-resistant, non-beta-lactamase-producing isolates, from pediatric patients. Mortensen JE; Himes SL Antimicrob Agents Chemother; 1990 Jul; 34(7):1456-8. PubMed ID: 2386375 [TBL] [Abstract][Full Text] [Related]
10. Isolates of β-lactamase-negative ampicillin-resistant Haemophilus influenzae causing invasive infections in Spain remain susceptible to cefotaxime and imipenem. García-Cobos S; Arroyo M; Pérez-Vázquez M; Aracil B; Lara N; Oteo J; Cercenado E; Campos J J Antimicrob Chemother; 2014 Jan; 69(1):111-6. PubMed ID: 23943391 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of second and third generation cephalosporins against ampicillin susceptible and resistant haemophilus influenzae. Burns JL; Wong K; Smith AL Infection; 1988; 16(5):293-6. PubMed ID: 3265130 [TBL] [Abstract][Full Text] [Related]
12. [Surveillance of antimicrobial susceptibility of Haemophilus influenzae isolates from children in Beijing, Shanghai, and Guangzhou 2000 - 2002]. Shen XZ; Lu Q; Deng L; Yu SJ; Zhang H; Deng QL; Jiang M; Hu YY; Yang YH Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1335-9. PubMed ID: 15387940 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cefixime, in comparison with other drugs, against Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis and Streptococcus pneumoniae. Stefani S; Pellegrino MB; D'Amico G; Privitera A; Privitera O; Maccarrone G; Russo G; Nicoletti G Chemotherapy; 1992; 38(1):36-45. PubMed ID: 1618002 [TBL] [Abstract][Full Text] [Related]
14. Ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime. García-Cobos S; Campos J; Lázaro E; Román F; Cercenado E; García-Rey C; Pérez-Vázquez M; Oteo J; de Abajo F Antimicrob Agents Chemother; 2007 Jul; 51(7):2564-73. PubMed ID: 17470649 [TBL] [Abstract][Full Text] [Related]
15. Novel mechanisms of resistance to β-lactam antibiotics in Haemophilus parainfluenzae: β-lactamase-negative ampicillin resistance and inhibitor-resistant TEM β-lactamases. García-Cobos S; Arroyo M; Campos J; Pérez-Vázquez M; Aracil B; Cercenado E; Orden B; Lara N; Oteo J J Antimicrob Chemother; 2013 May; 68(5):1054-9. PubMed ID: 23335113 [TBL] [Abstract][Full Text] [Related]
16. In-vitro activity of imipenem against 100 strains of serotype b and nontypable Haemophilus influenzae, including strains resistant to ampicillin, chloramphenicol or both. Campos JM; Gill CJ; Ahonkhai VI J Antimicrob Chemother; 1985 Nov; 16(5):549-54. PubMed ID: 3878361 [TBL] [Abstract][Full Text] [Related]
17. Beta-lactamase-positive strains of Haemophilus influenzae: susceptibility to and inactivation of beta-lactam antibiotics. Anderson EL; Robinson PA; Tu KK; Adams CR South Med J; 1985 Jun; 78(6):643-6. PubMed ID: 3873708 [TBL] [Abstract][Full Text] [Related]
18. In vitro activities and targets of three cephem antibiotics against Haemophilus influenzae. Mendelman PM; Henritzy LL; Chaffin DO; Lent K; Smith AL; Stull TL; Wiley EA Antimicrob Agents Chemother; 1989 Nov; 33(11):1878-82. PubMed ID: 2610499 [TBL] [Abstract][Full Text] [Related]
19. Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Canadian Study Group. Tremblay LD; L'Ecuyer J; Provencher P; Bergeron MG CMAJ; 1990 Nov; 143(9):895-901. PubMed ID: 2224717 [TBL] [Abstract][Full Text] [Related]
20. Limited in vitro activity of cefamandole against 100 beta-lactamase- and non-beta-lactamase-producing Haemophilus influenzae strains: comparison of moxalactam, chloramphenicol, and ampicillin. Bergeron MG; Claveau S; Simard P Antimicrob Agents Chemother; 1981 Jan; 19(1):101-5. PubMed ID: 6454379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]